Refine by
Viral Vector Suppliers In Austria
5 companies found
based inWien, AUSTRIA
BlueSky Immunotherapies GmbH (Ltd.) is a clinical-stage biotech company. The company’s business is based on its own proprietary, novel technology platform for interferon-inducing viral vectors (delNS). Interferons have immunostimulatory and ...
The high level of interferon induced by the delNS vector activates immunological defence reactions against cancer. It also stimulates the production of antiviral ...
based inWaltham, MASSACHUSETTS (USA)
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are ...
Connections that can turn a discovery into a cure. End-to-end solutions from research to commercialization. Connect every phase of your cell and gene therapy journey. We connect you to end-to-end cell and gene therapy solutions that help you deliver ...
based inNorwood, MASSACHUSETTS (USA)
Advanced Instruments is dedicated to increasing productivity and ensuring quality in the biotechnology, pharmaceutical, clinical and food & beverage industries. With a focus on innovations that anticipate and overcome customer pain points, we help ...
based inVienna, AUSTRIA
A spin-off from the University of Veterinary Medicine Vienna, ViruSure was founded in 2005 by Dr. Andy Bailey to offer a range of biosafety testing services to biopharmaceutical product manufacturers. Since 2008, ViruSure’s in vitro and molecular ...
Gene therapy has brought hope to many diseases with unmet clinical need. The potential to permanently cure the patient through replacement of a defective gene with a healthy gene underscores the surge of interest in this exciting biopharma ...
based inVienna, AUSTRIA
Nuvonis is a biotech company based in Vienna, Austria, providing innovative Cell Banks and technical support for vaccine development. The Nuvonis team is highly experienced in all aspects of vaccine production, both in small biotech companies up to ...